The new varieties could be used as a substitute for soybeans in animal feed, reducing China's grain imports by millions of ...

Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease over-enrolled to 143 total participants, on track to report topline data in the ...

Natural products industry companies share overviews on the latest science on their branded ingredients and formulations to ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Painesville meat processor Weaver Meats is expanding its facility in order to increase production capacity. The company expects the 18,500-square-foot expansion at its 380 Fountain Ave. facility ...

Chhaava’ continues to dominate the box office with total earnings of ₹535.55 crore, showcasing Vicky Kaushal's stellar ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

In February, three insiders bought a combined total of $6.61 million in Septerna shares at an average price of $5.79 per ...

Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Company expect ...

Ahmedabad: The sale of vitamins, minerals, and nutraceutical supplements skyrocketed in 2024, witnessing a staggering 61% ...

There is insufficient evidence to support exclusive enteral nutrition as an adjunctive therapy for active ulcerative colitis, ...